Enovis (ENOV) Competitors $34.74 +1.72 (+5.21%) As of 07/8/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENOV vs. CG, AVNT, BC, DOV, EVR, ITT, IVZ, GKOS, IRTC, and NARIShould you be buying Enovis stock or one of its competitors? The main competitors of Enovis include Carlyle Group (CG), Avient (AVNT), Brunswick (BC), Dover (DOV), Evercore (EVR), ITT (ITT), Invesco (IVZ), Glaukos (GKOS), iRhythm Technologies (IRTC), and Inari Medical (NARI). Enovis vs. Its Competitors Carlyle Group Avient Brunswick Dover Evercore ITT Invesco Glaukos iRhythm Technologies Inari Medical Carlyle Group (NASDAQ:CG) and Enovis (NYSE:ENOV) are related companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability. Do insiders and institutionals believe in CG or ENOV? 55.9% of Carlyle Group shares are held by institutional investors. Comparatively, 98.5% of Enovis shares are held by institutional investors. 26.3% of Carlyle Group shares are held by company insiders. Comparatively, 2.7% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings & valuation, CG or ENOV? Carlyle Group has higher revenue and earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Carlyle Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarlyle Group$5.43B3.71$1.02B$2.9518.92Enovis$2.11B0.94-$825.49M-$13.95-2.49 Do analysts recommend CG or ENOV? Carlyle Group currently has a consensus price target of $53.00, suggesting a potential downside of 5.02%. Enovis has a consensus price target of $55.60, suggesting a potential upside of 60.05%. Given Enovis' stronger consensus rating and higher probable upside, analysts plainly believe Enovis is more favorable than Carlyle Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carlyle Group 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38Enovis 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is CG or ENOV more profitable? Carlyle Group has a net margin of 19.00% compared to Enovis' net margin of -37.65%. Carlyle Group's return on equity of 23.78% beat Enovis' return on equity.Company Net Margins Return on Equity Return on Assets Carlyle Group19.00% 23.78% 6.40% Enovis -37.65%5.99%3.44% Which has more risk & volatility, CG or ENOV? Carlyle Group has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500. Comparatively, Enovis has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Does the media refer more to CG or ENOV? In the previous week, Carlyle Group had 7 more articles in the media than Enovis. MarketBeat recorded 14 mentions for Carlyle Group and 7 mentions for Enovis. Carlyle Group's average media sentiment score of 1.05 beat Enovis' score of 1.01 indicating that Carlyle Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlyle Group 8 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enovis 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCarlyle Group beats Enovis on 13 of the 16 factors compared between the two stocks. Get Enovis News Delivered to You Automatically Sign up to receive the latest news and ratings for ENOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENOV vs. The Competition Export to ExcelMetricEnovisMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$1.89B$1.97B$5.47B$20.52BDividend YieldN/AN/A5.25%3.76%P/E Ratio-2.4935.7727.0027.79Price / Sales0.9415.86435.7540.48Price / Cash1.7254.5536.8222.26Price / Book0.778.567.984.58Net Income-$825.49M-$62.39M$3.16B$982.91M7 Day Performance3.96%4.26%2.40%0.41%1 Month Performance5.46%4.34%2.19%3.59%1 Year Performance-20.59%9.18%33.82%14.47% Enovis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENOVEnovis3.4657 of 5 stars$34.74+5.2%$55.60+60.0%-21.7%$1.89B$2.11B-2.497,367News CoveragePositive NewsAnalyst ForecastCGCarlyle Group4.2819 of 5 stars$51.40+0.4%$53.00+3.1%+37.8%$18.48B$5.43B17.422,300Positive NewsAVNTAvient4.6758 of 5 stars$32.36-1.5%$46.80+44.6%-20.0%$3.01B$3.24B12.359,200BCBrunswick4.4079 of 5 stars$55.29-0.5%$70.00+26.6%-16.5%$3.65B$5.24B45.6915,000DOVDover4.7057 of 5 stars$183.34+0.0%$208.58+13.8%+6.8%$25.13B$7.75B11.0424,000Trending NewsEVREvercore3.9066 of 5 stars$270.85+0.7%$250.57-7.5%+34.3%$10.52B$2.98B25.922,380Analyst ForecastITTITT4.2986 of 5 stars$156.93-0.6%$165.50+5.5%+24.4%$12.43B$3.63B24.9511,700IVZInvesco4.7742 of 5 stars$15.80+0.6%$17.42+10.2%+11.8%$7.03B$6.07B12.648,500GKOSGlaukos4.556 of 5 stars$103.42+2.0%$134.67+30.2%-16.3%$5.80B$383.48M0.00780Positive NewsIRTCiRhythm Technologies1.0367 of 5 stars$153.96-0.5%$138.60-10.0%+40.4%$4.94B$591.84M0.002,000News CoverageNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800 Related Companies and Tools Related Companies Carlyle Group Competitors Avient Competitors Brunswick Competitors Dover Competitors Evercore Competitors ITT Competitors Invesco Competitors Glaukos Competitors iRhythm Technologies Competitors Inari Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ENOV) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enovis Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Enovis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
